A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...

The market has left medical device stocks in the dust, but heart monitor maker iRhythm Technologies is proving an exception. As doctors and hospitals slap its Zio patch monitors on more patients, the ...

iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...

iRhythm Technologies IRTC recently announced initial research findings on the post-market, real-world performance of the Zio monitor, IRTC’s next-generation Zio long-term continuous monitoring (LTCM) ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...

iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. The ...

New research presented at the Heart Rhythm Society’s 2026 meeting shows that 14-day continuous monitoring with iRhythm’s Zio patch detects significantly more atrial fibrillation recurrences than the ...

NASDAQ:MDGL: $1.2 billion (11.6% of AUM) NASDAQ:INSM: $842.9 million (8.4% of AUM) NASDAQ:PTCT: $588.4 million (5.9% of AUM) NASDAQ:ARGX: $566.4 million (5.7% of AUM) NASDAQ:PTGX: $441.9 million (4.4% ...